首页> 外文期刊>Current Medicinal Chemistry >Cationic Lipid-DNA Complexes for Gene Therapy: Understanding the Relationship Between Complex Structure and Gene Delivery Pathways at the Molecular Level
【24h】

Cationic Lipid-DNA Complexes for Gene Therapy: Understanding the Relationship Between Complex Structure and Gene Delivery Pathways at the Molecular Level

机译:阳离子脂质-DNA复合物的基因治疗:在分子水平上理解复杂结构与基因传递途径之间的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Cationic liposomes (CLs) are used as gene vectors (carriers) in worldwide human clinical trials of non-viral gene therapy. These lipid-gene complexes have the potential of transferring large pieces of DNA of up to 1 million base-pairs into cells. As our understanding of the mechanisms of action of CL-DNA complexes remains poor, transfection efficiencies are still low when compared to gene delivery with viral vectors. We describe recent studies with a combination of techniques (synchrotron x-ray diffraction for structure determination, laser-scanning confocal microscopy to probe the interactions of CL-DNA particles with cells, and luciferase reporter-gene expression assays to measure transfection efficiencies in mammalian cells), which collectively are beginning to unravel the relationship between the distinctly structured CL-DNA complexes and their transfection efficiency. The work described here is applicable to transfection optimization in ex vivo cell transfection, where cells are removed and returned to patients after transfection. CL-DNA complexes primarily form a multilayered sandwich structure with DNA layered between the cationic lipids (labeled Lα C). On rare occasions, an inverted hexagonal structure with DNA encapsulated in lipid tubules (labeled HII C) is observed. A major recent insight is that for Lα C complexes the membrane charge density σM of the CL-vector, rather than the charge of the cationic lipid alone, is a key universal parameter that governs the transfection efficiency of Lα C complexes in cells. The parameter σM is a measure of the average charge per unit area of the membrane, thus taking into account the amount of neutral lipids. In contrast to Lα C complexes, HII C complexes containing the lipid 1,2-dioleoyl-sn-glycerophosphatidylethanolamine (DOPE) exhibit no dependence on ?M. The current limiting factor to transfection by cationic lipid vectors appears to be the tight association of a fraction of the delivered exogenous DNA with cationic cellular molecules, which may prevent optimal transcriptional activity. Future directions are outlined, which make use of surface-functionalized CL-DNA complexes suitable for transfection in vivo.
机译:阳离子脂质体(CLs)在非病毒基因疗法的全球人类临床试验中用作基因载体(载体)。这些脂质基因复合物具有将多达一百万个碱基对的大片段DNA转移到细胞中的潜力。由于我们对CL-DNA复合物的作用机理的了解仍然很差,与病毒载体的基因递送相比,转染效率仍然很低。我们描述了结合技术的最新研究(同步加速器X射线衍射用于结构确定,激光扫描共聚焦显微镜以探测CL-DNA颗粒与细胞的相互作用以及萤光素酶报道基因表达测定法以测量哺乳动物细胞中的转染效率) ),这些都开始揭示结构独特的CL-DNA复合物与其转染效率之间的关系。此处描述的工作适用于离体细胞转染中的转染优化,转染后将细胞取出并送回患者手中。 CL-DNA复合物主要形成多层夹心结构,其中DNA夹在阳离子脂质(标记为LαC)之间。在极少数情况下,会观察到DNA封装在脂质小管(标记为HII C)中的倒六边形结构。最近的主要见解是,对于LαC复合物,CL载体的膜电荷密度σM而不是单独的阳离子脂质的电荷,是控制LαC复合物在细胞中转染效率的关键通用参数。参数σM是膜单位面积平均电荷的量度,因此考虑了中性脂质的量。与LαC络合物相反,含有脂质1,2-二油酰基-sn-甘油磷脂酰乙醇胺(DOPE)的HII C络合物不依赖于M。通过阳离子脂质载体转染的当前限制因素似乎是递送的外源DNA的一部分与阳离子细胞分子的紧密结合,这可能阻止最佳的转录活性。概述了未来的方向,这些方向利用了适用于体内转染的表面功能化CL-DNA复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号